N-[(1-n butyl-4-piperidyl)methyl] indole-3-carboxamide → Quinolizidin-2-ylmethyl thiazolo[3,2-a]indole-9-Carboxamide
Reaction equation
[S:1]1[C:5]2=[C:6]([C:13]([OH:15])=O)[C:7]3[CH:8]=[CH:9][CH:10]=[CH:11][C:12]=3[N:4]2[CH:3]=[CH:2]1.[CH2:16]1[CH:25]2[N:20]([CH2:21][CH2:22][CH2:23][CH2:24]2)[CH2:19][CH2:18][CH:17]1[CH2:26]N.C([N:32]1CCC(CNC(C2C3C(=CC=CC=3)NC=2)=O)CC1)CCC>>[CH2:16]1[CH:25]2[N:20]([CH2:21][CH2:22][CH2:23][CH2:24]2)[CH2:19][CH2:18][CH:17]1[CH2:26][C:2]1[S:1][C:5]2=[C:6]([C:13]([NH2:32])=[O:15])[C:7]3[CH:8]=[CH:9][CH:10]=[CH:11][C:12]=3[N:4]2[CH:3]=1Participants
4
Procedure
Thiazolo[3,2-a]indole-9-carboxylic acid (D16) is converted to its acid chloride and reacted with eq-quinolizidin-2-ylmethylamine (D12) using a procedure analogous to that described in Description 1b.
Sources & evidence
- ORD record
- ord-da06a41a15504430b6d1beb8199f3098
- Source dataset
- uspto-grants-1998_12
- Patent number
- US05852014
Reaction notes
Loading…